L&K Biomed Balance Sheet Health
Financial Health criteria checks 3/6
L&K Biomed has a total shareholder equity of ₩32.2B and total debt of ₩22.4B, which brings its debt-to-equity ratio to 69.6%. Its total assets and total liabilities are ₩78.4B and ₩46.3B respectively. L&K Biomed's EBIT is ₩1.2B making its interest coverage ratio 1. It has cash and short-term investments of ₩22.5B.
Key information
69.6%
Debt to equity ratio
₩22.39b
Debt
| Interest coverage ratio | 1x |
| Cash | ₩22.53b |
| Equity | ₩32.16b |
| Total liabilities | ₩46.25b |
| Total assets | ₩78.41b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: A156100's short term assets (₩59.8B) exceed its short term liabilities (₩36.4B).
Long Term Liabilities: A156100's short term assets (₩59.8B) exceed its long term liabilities (₩9.9B).
Debt to Equity History and Analysis
Debt Level: A156100 has more cash than its total debt.
Reducing Debt: A156100's debt to equity ratio has increased from 55.9% to 69.6% over the past 5 years.
Debt Coverage: A156100's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: A156100's interest payments on its debt are not well covered by EBIT (1x coverage).